Why Bother? Lab Monitoring in Beta-Lactam Outpatient Parenteral Antimicrobial Therapy.
作者信息
Zukauckas Kelsea, Benefield Russell J, Newman Michael, Certain Laura
机构信息
University of Utah Health, Department of Pharmacy, Salt Lake City, Utah, USA.
University of Utah Health, Data Science Services, Salt Lake City, Utah, USA.
出版信息
Antimicrob Agents Chemother. 2022 Jun 21;66(6):e0057922. doi: 10.1128/aac.00579-22. Epub 2022 May 11.
Abstract
摘要
相似文献
1
Why Bother? Lab Monitoring in Beta-Lactam Outpatient Parenteral Antimicrobial Therapy.何必麻烦？β-内酰胺类门诊胃肠外抗菌治疗中的实验室监测
Antimicrob Agents Chemother. 2022 Jun 21;66(6):e0057922. doi: 10.1128/aac.00579-22. Epub 2022 May 11.
2
Outpatient parenteral antimicrobial therapy: Recent developments and future prospects.门诊胃肠外抗菌治疗：最新进展与未来展望。
Curr Opin Investig Drugs. 2010 Aug;11(8):929-39.
3
Quantifying the Time to Administer Outpatient Parenteral Antimicrobial Therapy: A Missed Opportunity to Compensate for the Value of Infectious Diseases.量化门诊肠外抗菌治疗的时间：弥补感染病价值的错失机会。
Clin Infect Dis. 2024 Aug 16;79(2):348-350. doi: 10.1093/cid/ciae262.
4
Off-site facilities: Friend or foe of outpatient parenteral antimicrobial therapy (OPAT)?非现场设施：门诊胃肠外抗菌治疗（OPAT）的助力还是阻力？
Infect Control Hosp Epidemiol. 2024 Jun;45(6):798-799. doi: 10.1017/ice.2024.20. Epub 2024 Feb 12.
5
Subcutaneous ertapenem delivered by an Australian outpatient parenteral antimicrobial therapy service: a retrospective comparative efficacy study.澳大利亚门诊患者的肠外抗菌治疗服务：回顾性比较疗效研究。
Intern Med J. 2021 Oct;51(10):1717-1721. doi: 10.1111/imj.15511.
6
Comparative outcomes of β-lactam antibiotics in outpatient parenteral antibiotic therapy: treatment success, readmissions and antibiotic switches.β-内酰胺类抗生素在门诊胃肠外抗生素治疗中的比较结果：治疗成功率、再入院率及抗生素更换情况
J Antimicrob Chemother. 2015 Aug;70(8):2389-96. doi: 10.1093/jac/dkv130. Epub 2015 May 29.
7
Discharge Delays and Costs Associated With Outpatient Parenteral Antimicrobial Therapy for High-Priced Antibiotics.门诊肠外抗菌治疗高价抗生素相关的出院延迟和费用。
Clin Infect Dis. 2020 Oct 23;71(7):e88-e93. doi: 10.1093/cid/ciz1076.
8
Maximising the opportunity of a self-administration outpatient parenteral antimicrobial therapy pathway.最大化自我管理门诊静脉注射抗菌治疗途径的机会。
Br J Nurs. 2021 Jan 28;30(2):S4-S10. doi: 10.12968/bjon.2021.30.2.S4.
9
Outpatient parenteral antimicrobial therapy for orthopedic infections - a successful public healthcare experience in Brazil.骨科感染的门诊胃肠外抗菌治疗——巴西一次成功的公共医疗经验。
Braz J Infect Dis. 2016 May-Jun;20(3):272-5. doi: 10.1016/j.bjid.2016.03.005. Epub 2016 Apr 18.
10
[Scaling up Outpatient Parenteral Antimicrobial Therapy (OPAT) service in the Netherlands].[扩大荷兰门诊胃肠外抗菌治疗（OPAT）服务]
Ned Tijdschr Geneeskd. 2023 Mar 8;167:D7149.
引用本文的文献
1
Impact of a nurse practitioner-led dedicated outpatient parenteral antibiotic therapy clinic on patient outcomes and administrative workload: a retrospective cohort study.执业护士主导的门诊专用肠外抗生素治疗诊所对患者预后及行政工作量的影响：一项回顾性队列研究
Ther Adv Infect Dis. 2024 Dec 23;11:20499361241305308. doi: 10.1177/20499361241305308. eCollection 2024 Jan-Dec.
2
Making the EHR Work for You-Modifications of an Electronic Health Record System to Improve Tracking and Management of Patients Receiving Outpatient Parenteral Antibiotic Therapy.让电子健康记录系统为您所用——对电子健康记录系统进行修改以改善接受门诊胃肠外抗生素治疗患者的跟踪与管理
Open Forum Infect Dis. 2024 Jan 12;11(2):ofae005. doi: 10.1093/ofid/ofae005. eCollection 2024 Feb.
3
Serious Adverse Events and Laboratory Monitoring Regimens for Outpatient Parenteral Antimicrobial Therapy With Cefazolin and Ceftriaxone.头孢唑林和头孢曲松门诊胃肠外抗菌治疗的严重不良事件及实验室监测方案
Open Forum Infect Dis. 2023 Dec 2;10(12):ofad606. doi: 10.1093/ofid/ofad606. eCollection 2023 Dec.
4
Taking the route less traveled: on the way to COpAT.走少有人走的路：通往协同自适应放疗（COpAT）之路。
Ther Adv Infect Dis. 2023 Aug 15;10:20499361231192771. doi: 10.1177/20499361231192771. eCollection 2023 Jan-Dec.
本文引用的文献
1
2018 Infectious Diseases Society of America Clinical Practice Guideline for the Management of Outpatient Parenteral Antimicrobial Therapy.2018 年美国传染病学会门诊患者接受肠外抗菌治疗管理临床实践指南。
Clin Infect Dis. 2019 Jan 1;68(1):e1-e35. doi: 10.1093/cid/ciy745.
2
Rates of and Risk Factors for Adverse Drug Events in Outpatient Parenteral Antimicrobial Therapy.门诊肠外抗菌治疗药物不良事件的发生率和危险因素。
Clin Infect Dis. 2018 Jan 6;66(1):11-19. doi: 10.1093/cid/cix733.
3
Peripheral blood eosinophilia and hypersensitivity reactions among patients receiving outpatient parenteral antibiotics.接受门诊胃肠外抗生素治疗患者的外周血嗜酸性粒细胞增多及过敏反应
J Allergy Clin Immunol. 2015 Nov;136(5):1288-94.e1. doi: 10.1016/j.jaci.2015.04.005. Epub 2015 May 14.
4
The Impact of an Infectious Diseases Transition Service on the Care of Outpatients on Parenteral Antimicrobial Therapy.传染病过渡服务对接受肠外抗菌治疗的门诊患者护理的影响。
J Pharm Technol. 2013 Oct;29(5):205-214. doi: 10.1177/8755122513500922.
5
A national survey of infectious disease practitioners on their use of outpatient parenteral antimicrobial therapy (OPAT).一项针对传染病医师使用门诊患者静脉用抗菌药物治疗（OPAT）的全国性调查。
Infect Dis (Lond). 2015 Jan;47(1):39-45. doi: 10.3109/00365548.2014.967290. Epub 2014 Nov 21.
6
Monitoring of Outpatient Parenteral Antimicrobial Therapy and Implementation of Clinical Pharmacy Services at a Community Hospital Infusion Unit.社区医院输液室门诊肠外抗菌治疗监测及临床药学服务的实施
J Pharm Pract. 2015 Oct;28(5):462-8. doi: 10.1177/0897190014544786. Epub 2014 Aug 8.
7
Association of laboratory test result availability and rehospitalizations in an outpatient parenteral antimicrobial therapy programme.实验室检验结果可得性与门诊肠外抗菌治疗方案再入院的关联。
J Antimicrob Chemother. 2014 Jan;69(1):228-33. doi: 10.1093/jac/dkt303. Epub 2013 Jul 25.
8
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.急性肾损伤网络：改善急性肾损伤预后的倡议报告
Crit Care. 2007;11(2):R31. doi: 10.1186/cc5713.
9
Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.急性肾衰竭——定义、预后指标、动物模型、液体治疗及信息技术需求：急性透析质量倡议（ADQI）小组第二次国际共识会议
Crit Care. 2004 Aug;8(4):R204-12. doi: 10.1186/cc2872. Epub 2004 May 24.
10
Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.脓毒症与器官衰竭的定义以及脓毒症创新疗法的使用指南。ACCP/SCCM共识会议委员会。美国胸科医师学会/危重病医学会。
Chest. 1992 Jun;101(6):1644-55. doi: 10.1378/chest.101.6.1644.
Zotero 插件